Free Trial

Candel Therapeutics (CADL) Institutional Ownership

Candel Therapeutics logo
$6.30 -0.05 (-0.71%)
As of 11:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Candel Therapeutics (NASDAQ:CADL)

Current
Institutional Ownership
Percentage
13.93%
Number of
Institutional Buyers
(last 12 months)
47
Total
Institutional Inflows
(last 12 months)
$77.32M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$3.73M
Get CADL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CADL Institutional Buying and Selling by Quarter

Candel Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2025XTX Topco Ltd74,629$378K0.0%N/A0.149%
8/12/2025Rhumbline Advisers54,498$276K0.0%+63.6%0.109%
8/12/2025JPMorgan Chase & Co.19,533$99K0.0%+36.9%0.039%
8/8/2025 Intech Investment Management LLC23,871$121K0.0%-16.4%0.048%
8/8/2025 Geode Capital Management LLC903,970$4.58M0.0%+31.5%1.804%
8/7/2025 Los Angeles Capital Management LLC24,810$126K0.0%N/A0.050%
7/18/2025 Tanager Wealth Management LLP196,631$995K0.1%N/A0.392%
7/17/2025 Janney Montgomery Scott LLC27,290$138K0.0%+29.4%0.054%
7/11/2025 Halter Ferguson Financial Inc.776,516$3.93M1.4%+12.0%1.550%
6/27/2025Goldman Sachs Group Inc.54,666$309K0.0%-16.2%0.109%
5/29/2025Rhumbline Advisers33,302$188K0.0%+26.8%0.066%
5/19/2025Acorn Capital Advisors LLC2,152,252$12.16M7.9%+11.0%4.368%
5/16/2025Goldman Sachs Group Inc.54,666$309K0.0%-16.2%0.111%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.16,748$95K0.0%+37.7%0.034%
5/15/2025Baker BROS. Advisors LP2,437,189$13.77M0.2%-18.3%4.947%
5/14/2025Corebridge Financial Inc.13,933$79K0.0%+29.4%0.028%
5/14/2025 AlphaQuest LLC10,870$61K0.0%N/A0.022%
5/14/2025 EntryPoint Capital LLC17,907$101K0.0%N/A0.036%
5/12/2025Nuveen LLC78,145$442K0.0%N/A0.159%
5/12/2025Invesco Ltd.10,413$59K0.0%N/A0.021%
5/12/2025 Taylor Financial Group Inc.10,000$56K0.0%N/A0.020%
5/9/2025Deutsche Bank AG26,211$148K0.0%-16.8%0.053%
5/9/2025Charles Schwab Investment Management Inc.83,880$474K0.0%+60.7%0.170%
5/9/2025 Halter Ferguson Financial Inc.693,153$3.92M2.0%+1.7%1.407%
5/7/2025 HB Wealth Management LLC94,300$533K0.0%+8.0%0.191%
5/5/2025 Private Advisor Group LLC10,350$58K0.0%N/A0.022%
4/30/2025 Stratos Wealth Advisors LLC23,000$130K0.0%N/A0.049%
4/29/2025 Bank of New York Mellon Corp60,759$343K0.0%+35.1%0.129%
4/17/2025 Janney Montgomery Scott LLC21,090$119K0.0%+104.3%0.045%
4/8/2025Rhumbline Advisers33,302$188K0.0%+26.8%0.071%
2/17/2025Squarepoint Ops LLC19,311$168K0.0%+86.6%0.059%
2/17/2025Nuveen Asset Management LLC68,226$592K0.0%+3.0%0.210%
2/17/2025Maven Securities LTD51,731$449K0.0%N/A0.159%
2/17/2025Millennium Management LLC31,626$275K0.0%+130.6%0.097%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,165$106K0.0%+12.4%0.037%
2/17/2025Deutsche Bank AG31,522$274K0.0%+5,814.1%0.097%
2/17/2025Bridgeway Capital Management LLC77,195$670K0.0%-4.2%0.238%
2/17/2025Braidwell LP1,600,000$13.89M0.4%N/A4.926%
2/17/2025Baker BROS. Advisors LP2,981,983$25.88M0.3%N/A9.181%
2/17/2025Bank of America Corp DE66,811$580K0.0%+205.6%0.206%
Alex’s “Next Magnificent Seven” stocks (Ad)

The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.

Watch the “Next Magnificent Seven” presentation here
2/17/2025BNP Paribas Financial Markets3,434$30K0.0%N/A0.011%
2/17/2025Acorn Capital Advisors LLC1,939,644$16.84M9.2%N/A5.972%
2/14/2025Northern Trust Corp165,021$1.43M0.0%+3.9%0.508%
2/14/2025Oxford Asset Management LLP12,003$104K0.1%N/A0.037%
2/14/2025Birchview Capital LP60,000$521K0.4%N/A0.185%
2/14/2025Heights Capital Management Inc.30,000$260K0.1%N/A0.092%
2/14/2025MetLife Investment Management LLC13,773$120K0.0%+9.7%0.042%
2/13/2025Portolan Capital Management LLC753,745$6.54M0.4%N/A2.321%
2/13/2025Barclays PLC34,317$297K0.0%+19.6%0.106%
2/13/2025Russell Investments Group Ltd.3,753$33K0.0%+75.1%0.012%
2/13/2025Wells Fargo & Company MN10,122$88K0.0%+63.6%0.031%
2/12/2025 Geode Capital Management LLC455,424$3.95M0.0%+1.4%1.402%
2/12/2025JPMorgan Chase & Co.10,426$90K0.0%+15.2%0.032%
2/11/2025LPL Financial LLC10,703$93K0.0%N/A0.033%
2/11/2025 Halter Ferguson Financial Inc.681,334$5.91M2.4%+123.7%2.098%
2/10/2025 Commonwealth Equity Services LLC41,098$357K0.0%N/A0.127%
2/6/2025Charles Schwab Investment Management Inc.52,190$453K0.0%+11.6%0.161%
2/5/2025 Oppenheimer & Co. Inc.37,915$329K0.0%N/A0.117%
1/30/2025Rhumbline Advisers26,272$228K0.0%+17.0%0.081%
1/30/2025 Vontobel Holding Ltd.19,000$165K0.0%-13.6%0.058%
1/15/2025 HB Wealth Management LLC87,300$696K0.0%+54.1%0.269%
12/26/2024JPMorgan Chase & Co.9,051$63K0.0%-53.2%0.028%
11/19/2024Barclays PLC28,688$199K0.0%+327.1%0.088%
11/16/2024 Geode Capital Management LLC448,997$3.11M0.0%+12.8%1.399%
11/15/2024Barclays PLC28,688$199K0.0%+327.1%0.089%
11/15/2024MML Investors Services LLC22,313$155K0.0%-69.6%0.070%
11/15/2024State Street Corp492,005$3.41M0.0%+4.1%1.534%
11/15/2024Atom Investors LP14,873$103K0.0%N/A0.046%
11/14/2024MetLife Investment Management LLC12,558$87K0.0%N/A0.039%
11/13/2024FMR LLC6,573$46K0.0%N/A0.020%
9/16/2024Point72 DIFC Ltd4,927$31K0.0%N/A0.017%
9/16/2024Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088%
8/14/2024Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088%
8/14/2024Point72 DIFC Ltd4,927$31K0.0%N/A0.017%
8/13/2024Sands Capital Ventures LLC405,837$2.52M0.8%-50.0%1.364%
8/9/2024Renaissance Technologies LLC20,600$128K0.0%-63.8%0.069%
8/1/2024Rhumbline Advisers22,985$143K0.0%N/A0.077%
7/26/2024 Bank of New York Mellon Corp54,449$338K0.0%N/A0.183%
1/29/2024Baystate Wealth Management LLC76,910$113K0.0%-21.0%0.266%
5/10/2023 Resources Investment Advisors LLC.25,428$34K0.0%N/A0.088%
4/25/2023Baystate Wealth Management LLC105,854$143K0.0%N/A0.366%
11/14/2022Point72 Asset Management L.P.403,131$1.27M0.0%-45.7%1.395%
5/6/2022 Empirical Asset Management LLC12,000$61K0.1%N/A0.042%
4/26/2022Kestra Advisory Services LLC12,500$64K0.0%N/A0.044%
2/15/2022Northpond Ventures LLC1,935,215$15.13M5.3%N/A6.745%
2/15/2022683 Capital Management LLC40,929$320K0.0%N/A0.143%
11/15/2021Caas Capital Management LP50,000$542K0.0%N/A0.174%
11/15/2021Franklin Resources Inc.1,125,000$12.20M0.0%N/A3.921%
11/9/2021BlackRock Inc.22,326$242K0.0%N/A0.078%
(Data available from 1/1/2016 forward)

CADL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CADL shares?

During the previous two years, 55 institutional investors and hedge funds held shares of Candel Therapeutics. The most heavily invested institutionals were Braidwell LP ($13.89M), Baker BROS. Advisors LP ($13.77M), Acorn Capital Advisors LLC ($12.16M), Portolan Capital Management LLC ($6.54M), Geode Capital Management LLC ($4.58M), Halter Ferguson Financial Inc. ($3.93M), and State Street Corp ($3.41M).Learn more on Candel Therapeutics' institutional investors.

What percentage of Candel Therapeutics' stock is owned by institutional investors?

13.93% of Candel Therapeutics' stock is owned by institutional investors. Learn more on CADL's institutional investor holdings.

Which institutional investors have been buying Candel Therapeutics' stock?

Of the 47 institutional investors that purchased Candel Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($2.98M), Acorn Capital Advisors LLC ($2.15M), Braidwell LP ($1.60M), Portolan Capital Management LLC ($753.75K), Halter Ferguson Financial Inc. ($471.98K), Geode Capital Management LLC ($274.05K), and Tanager Wealth Management LLP ($196.63K).

How much institutional buying is happening at Candel Therapeutics?

Institutional investors have bought a total of 9,382,650 shares in the last 24 months. This purchase volume represents approximately $77.32M in transactions.

Which of Candel Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Candel Therapeutics stock in the last 24 months: Baker BROS. Advisors LP ($544.79K), MML Investors Services LLC ($51.06K), Goldman Sachs Group Inc. ($21.14K), JPMorgan Chase & Co. ($10.31K), Deutsche Bank AG ($5.31K), Intech Investment Management LLC ($4.70K), and Bridgeway Capital Management LLC ($3.40K).

How much institutional selling is happening at Candel Therapeutics?

Institutional investors have sold a total of 643,710 shares in the last 24 months. This volume of shares sold represents approximately $3.73M in transactions.



This page (NASDAQ:CADL) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners